Revolution Total Assets from 2010 to 2024

RVMD Stock  USD 57.50  0.75  1.32%   
Revolution Medicines' Total Assets are increasing over the years with slightly volatile fluctuation. Overall, Total Assets are expected to go to about 2.2 B this year. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals
 
Total Assets  
First Reported
2018-12-31
Previous Quarter
1.8 B
Current Value
1.8 B
Quarterly Volatility
548 M
 
Covid
Check Revolution Medicines financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Revolution Medicines' main balance sheet or income statement drivers, such as Net Interest Income of 49.5 M, Interest Income of 49.9 M or Depreciation And Amortization of 6.5 M, as well as many indicators such as Price To Sales Ratio of 294, Dividend Yield of 0.0 or PTB Ratio of 1.69. Revolution financial statements analysis is a perfect complement when working with Revolution Medicines Valuation or Volatility modules.
  
Check out the analysis of Revolution Medicines Correlation against competitors.
For information on how to trade Revolution Stock refer to our How to Trade Revolution Stock guide.

Latest Revolution Medicines' Total Assets Growth Pattern

Below is the plot of the Total Assets of Revolution Medicines over the last few years. Total assets refers to the total amount of Revolution Medicines assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Revolution Medicines books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Revolution Medicines' Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Revolution Medicines' overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 2.06 B10 Years Trend
Slightly volatile
   Total Assets   
       Timeline  

Revolution Total Assets Regression Statistics

Arithmetic Mean457,036,350
Geometric Mean88,213,542
Coefficient Of Variation159.17
Mean Deviation541,151,000
Median15,077,000
Standard Deviation727,474,232
Sample Variance529218.8T
Range2.1B
R-Value0.80
Mean Square Error205386.6T
R-Squared0.64
Significance0.0003
Slope130,096,624
Total Sum of Squares7409062.6T

Revolution Total Assets History

20242.2 B
20232.1 B
2022811.9 M
2021738 M
2020567.4 M
2019220.5 M
2018170.6 M

Other Fundumenentals of Revolution Medicines

Revolution Medicines Total Assets component correlations

1.00.89-0.96-0.980.990.90.980.991.01.00.850.9-0.93-0.97-0.88-0.090.8-0.91.0-0.33
1.00.88-0.96-0.980.990.890.970.991.01.00.850.9-0.94-0.97-0.89-0.10.79-0.91.0-0.33
0.890.88-0.75-0.910.820.990.880.910.870.880.820.93-0.71-0.89-0.65-0.290.92-0.80.89-0.22
-0.96-0.96-0.750.92-0.98-0.75-0.9-0.96-0.97-0.97-0.75-0.780.990.950.920.12-0.650.84-0.960.34
-0.98-0.98-0.910.92-0.97-0.92-0.96-0.98-0.98-0.98-0.88-0.950.910.970.820.1-0.870.87-0.980.41
0.990.990.82-0.98-0.970.830.940.980.990.990.810.86-0.97-0.96-0.92-0.040.73-0.90.99-0.36
0.90.890.99-0.75-0.920.830.920.910.880.890.860.94-0.71-0.87-0.64-0.180.94-0.810.89-0.24
0.980.970.88-0.9-0.960.940.920.960.960.960.90.92-0.85-0.91-0.8-0.010.84-0.870.96-0.32
0.990.990.91-0.96-0.980.980.910.960.990.990.830.9-0.93-0.98-0.87-0.190.81-0.891.0-0.32
1.01.00.87-0.97-0.980.990.880.960.991.00.830.89-0.95-0.97-0.9-0.110.78-0.91.0-0.34
1.01.00.88-0.97-0.980.990.890.960.991.00.830.9-0.95-0.97-0.89-0.120.79-0.91.0-0.34
0.850.850.82-0.75-0.880.810.860.90.830.830.830.83-0.71-0.76-0.530.160.88-0.620.82-0.22
0.90.90.93-0.78-0.950.860.940.920.90.890.90.83-0.78-0.89-0.7-0.150.94-0.830.91-0.54
-0.93-0.94-0.710.990.91-0.97-0.71-0.85-0.93-0.95-0.95-0.71-0.780.940.920.11-0.630.83-0.940.43
-0.97-0.97-0.890.950.97-0.96-0.87-0.91-0.98-0.97-0.97-0.76-0.890.940.870.31-0.790.87-0.980.38
-0.88-0.89-0.650.920.82-0.92-0.64-0.8-0.87-0.9-0.89-0.53-0.70.920.870.1-0.460.93-0.890.35
-0.09-0.1-0.290.120.1-0.04-0.18-0.01-0.19-0.11-0.120.16-0.150.110.310.1-0.170.07-0.150.01
0.80.790.92-0.65-0.870.730.940.840.810.780.790.880.94-0.63-0.79-0.46-0.17-0.630.8-0.41
-0.9-0.9-0.80.840.87-0.9-0.81-0.87-0.89-0.9-0.9-0.62-0.830.830.870.930.07-0.63-0.90.33
1.01.00.89-0.96-0.980.990.890.961.01.01.00.820.91-0.94-0.98-0.89-0.150.8-0.9-0.36
-0.33-0.33-0.220.340.41-0.36-0.24-0.32-0.32-0.34-0.34-0.22-0.540.430.380.350.01-0.410.33-0.36
Click cells to compare fundamentals

About Revolution Medicines Financial Statements

Revolution Medicines stakeholders use historical fundamental indicators, such as Revolution Medicines' Total Assets, to determine how well the company is positioned to perform in the future. Although Revolution Medicines investors may analyze each financial statement separately, they are all interrelated. For example, changes in Revolution Medicines' assets and liabilities are reflected in the revenues and expenses on Revolution Medicines' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Revolution Medicines. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Assets2.1 B2.2 B
Intangibles To Total Assets 0.04  0.03 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Revolution Medicines is a strong investment it is important to analyze Revolution Medicines' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Revolution Medicines' future performance. For an informed investment choice regarding Revolution Stock, refer to the following important reports:
Check out the analysis of Revolution Medicines Correlation against competitors.
For information on how to trade Revolution Stock refer to our How to Trade Revolution Stock guide.
You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Revolution Medicines. If investors know Revolution will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Revolution Medicines listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.71)
Revenue Per Share
0.005
Quarterly Revenue Growth
(0.95)
Return On Assets
(0.29)
Return On Equity
(0.47)
The market value of Revolution Medicines is measured differently than its book value, which is the value of Revolution that is recorded on the company's balance sheet. Investors also form their own opinion of Revolution Medicines' value that differs from its market value or its book value, called intrinsic value, which is Revolution Medicines' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Revolution Medicines' market value can be influenced by many factors that don't directly affect Revolution Medicines' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Revolution Medicines' value and its price as these two are different measures arrived at by different means. Investors typically determine if Revolution Medicines is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Revolution Medicines' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.